In Clinical Development:
A targeted and precise approach to seeing diseased cells
On Target Laboratories develops precise and innovative small molecules whose goal is to target and illuminate cancer and other diseased tissue.
Learn More About OTL
Our illuminating molecules are intended to become products that
enhance the doctors' ability to see diseased tissue clearly, improving their ability to treat cancer, autoimmune and other diseases.
See For Yourself
Unlike other dyes, our technology is very specific and sensitive to diseased tissue. Our goal is to develop products that can be implemented without additional burden to the patient or surgeon.
Why Our Difference Matters
OTL 38 is being studied in a Phase 2 ovarian cancer clinical trial. Additional trials have begun to test OTL38 in other cancers and disease states.
Our Research Projects
Video: OTL38 is being developed to illuminate cancer so surgeons can see with clarity
"If the surgeon can see it all.... He or she can easily remove it, but if you can't see it and you can't feel it and you can't detect it, it's going to stay there. The patient is going to be sewn back up with the disease inside."
This website uses marketing and tracking technologies. Opting out of this will opt you out of all cookies, except for those needed to run the website. Note that some products may not work as well without tracking cookies.Opt Out of Cookies